Naval Daver, MD¹, Jayastu Senapati, MD, MBBS, DM^1*, Abhishek Maiti, MBBS², Sanam Loghavi, MD³, Tapan M. Kadia, MD⁴, Courtney D. DiNardo, MD, MSCE¹, Naveen Pemmaraju, MD¹, Elias Jabbour, MD¹, Guillermo Montalban-Bravo, MD¹, Guilin Tang, MD, PhD^3*, Koji Sasaki, MD¹, Gautam Borthakur, MD¹, Musa Yilmaz, MD⁴, Joie Alvarez, BSN^1*, Sherry A. Pierce, BSN, BA^1*, Graciela M. Nogueras González, MPH^5*, Jing Ning^6*, Ghayas C. Issa, MD^7,8, Michael Andreeff, MD, PhD¹, Hussein A Abbas, MD, PhD¹, Farhad Ravandi, MD¹, Guillermo Garcia-Manero, MD⁹ and Hagop Kantarjian, MD¹⁰

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁵Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶department of biostatics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
⁹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Naval Daver, MD¹, Pau Montesinos, PhD, MD^2*, Ahmed Aribi, MD³, Giovanni Marconi, MD⁴, Jessica K. Altman, MD⁵, Eunice S. Wang, MD⁶, Gail J. Roboz, MD⁷, Patrick W. Burke, MD⁸, Gianluca Gaidano, MD, PhD⁹, Roland B. Walter, MD, PhD, MS¹⁰, Xavier Thomas, MD, PhD¹¹, Deepa Jeyakumar, MD¹², Daniel J. DeAngelo, MD, PhD¹³, Harry P. Erba, MD, PhD¹⁴, Elisabetta Todisco, MD, PhD^15*, Kebede H. Begna, MD¹⁶, Anjali Advani, MD¹⁷, Lauris Gastaud, MD^18*, Adolfo De La Fuente, MD^19*, Antonio Curti, MD, PhD²⁰, Lourdes M. Mendez, MD, PhD²¹, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath²², Nicolas Boissel, MD, PhD²³, Norbert Vey, MD²⁴, Christian Recher, MD, PhD²⁵, Thomas Longval, MD^26*, Uwe Platzbecker, MD²⁷, Silke Kapp-Schwoerer, MD^28*, Christoph Schliemann, MD^29*, Marina Konopleva, MD, PhD¹, Laura Torres, MD^2*, David A. Sallman, MD³⁰, Guido Marcucci, MD³¹, Naveen Pemmaraju, MD¹, Giovanni Martinelli, MD³², Hagop Kantarjian, MD³³, Callum M Sloss, PhD³⁴, Kara E Malcolm, RN^34*, Patrick A Zweidler-McKay, MD, PhD³⁴ and Kendra Sweet, MD³⁰

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Hematology Department, Hospital Universitario i Politecnico La Fe Valencia, Valencia, Spain
³Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁴IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori” - IRST, Bologna, Italy
⁵Northwestern University, Chicago, IL
⁶Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁷Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York, NY
⁸Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
⁹Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
¹⁰Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹¹Department of Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Lyon, France
¹²Division of Hematology/Oncology, UC Irvine Medical Center, Orange, CA
¹³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁴Hematologic Malignancies Clinic, Duke University Blood Cancer Center, Durham, NC
¹⁵IEO, European Institute of Oncology IRCCS, Milan, Milan, Italy
¹⁶Divison of Hematology, Mayo Clinic, Rochester, MN
¹⁷Taussig Cancer Institute / Leukemia Program, Cleveland Clinic, Cleveland, OH
¹⁸Centre Antoine Lacassagne, Nice Cedex 2, France
¹⁹MD Anderson Cancer Center, Madrid, ESP
²⁰IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
²¹Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA, Boston, MA
²²Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²³Hospital St. Louis, Paris, France
²⁴Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Marseille, France
²⁵Institut Universitaire du Cancer de Toulouse Oncopole, CHU de Toulouse and Université de Toulouse III, Toulouse, France
²⁶Laboratoire hématologie, APHP Hopital Saint Antoine, Paris, France
²⁷Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
²⁸Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
²⁹Department of Hematology, Oncolog and Pneumology, University of Münster, Münster, Germany
³⁰Department of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL
³¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
³²IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy
³³Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³⁴ImmunoGen, Inc., Waltham, MA

Ghayas C. Issa, MD¹, Ibrahim Aldoss, MD², John F. DiPersio, MD, PhD³, Branko Cuglievan, MD^4*, Richard M. Stone, MD⁵, Martha L. Arellano, MD⁶, Michael J. Thirman, MD⁷, Manish R. Patel, MD⁸, David Dickens, MD^9*, Shalini Shenoy, MD¹⁰, Neerav Shukla, MD^11*, Galit Rosen, MD¹², Rebecca G. Bagley, MA^12*, Michael L. Meyers, MD, PhD^12*, Kate Madigan, MD^12*, Peter Ordentlich, PhD^12*, Yu Gu, PhD^12*, Steven Smith, PhD^12*, Gerard M. McGeehan, PhD^12* and Eytan Stein, MD¹³

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²City of Hope, Duarte, CA
³Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁴Division of Pediatric Hematology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁷Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁸Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL
⁹Division of Pediatric Hematology and Oncology, University of Iowa, Iowa City, IA
¹⁰Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO
¹¹Department of Pediatrics, Memorial Sloan Kettering Cancer Center Pediatric Hematology/Oncology (PD), New York, NY
¹²Syndax Pharmaceuticals, Inc., Waltham, MA
¹³Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Harry P. Erba, MD, PhD¹, Amir T. Fathi, MD^2,3, Ghayas C. Issa, MD⁴, Jessica K. Altman, MD⁵, Pau Montesinos, MD, PhD^6*, Mrinal M. M. Patnaik, MD⁷, James M. Foran, MD⁸, Stephane De Botton, MD, PhD^9*, Maria R. Baer, MD¹⁰, Gary J. Schiller, MD¹¹, Roland B. Walter, MD, PhD, MS¹², Marina Kremyanskaya, MD, PhD¹³, Kristen M. Pettit¹⁴, Stephen A Strickland, MD, MSCI¹⁵, Blake Tomkinson, PhD, MBA^16*, Marilyn Tabachri, RN, BSN^16*, Mollie Leoni, MD^16*, Stephen Dale, MD^16* and Eunice S. Wang, MD¹⁷

¹Leukemia Program, Duke University Medical Center, Durham, NC
²Director of Leukemia Program, Massachusetts General Hospital, Boston, MA
³Associate Professor of Medicine, Harvard Medical School, Boston, MA
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
⁶Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
⁹Department of Haematology, Institut Gustave Roussy, Villejuif, France
¹⁰University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
¹¹David Geffen School of Medicine at UCLA, Los Angeles, CA
¹²Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹³Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁴Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
¹⁵Vanderbilt-Ingram Cancer Center, Nashville, TN
¹⁶Kura Oncology, Boston, MA
¹⁷Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Sameem Abedin, MD¹, Guru Subramanian Guru Murthy, MBBS², Aniko Szabo, PhD^3*, Mehdi Hamadani, MD⁴, Laura C. Michaelis, MD⁵, Karen Carlson, MD, PhD¹, Lyndsey Runaas, MD^1*, Katelyn Gauger^6*, Avinash G Desai, MD⁷, Mary M Chen, MD⁸, Alexandra M. Harrington, MD, MT(ASCP)⁴ and Ehab L. Atallah, MD¹

¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
²Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
⁴Medical College of Wisconsin, Milwaukee, WI
⁵Division of Hematology/Oncology, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
⁶Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee
⁷Actinium Pharmaceuticals, New York, NY
⁸Actinium Pharmaceuticals, Inc., New York, MD

Soheil Meshinchi, M.D., Ph.D.¹, Lane Miller, MD, MSc^2*, Stephanie Massaro, MD, MPH^3*, Robin Williams, MD, MS⁴, Elizabeth Krieger, MD⁵, Melinda Pauly, MD^6,7, Catherine Nelson, DO⁸, Deepa Bhojwani, MD⁹, Rebecca Johnson, MD^10*, Terzah M. Horton, MD, PhD¹¹, Hamayun Imran, MD, MSc¹², Wen-I Chang, MD^13*, Philip Neff, MD^14*, Matthew Kutny, MD^15*, Raul C. Ribeiro, MD¹⁶, Felipe Bautista, MD^17*, Terri Guinipero, MD^18*, Kate Murray^19*, Alex Butte^19* and Arturo Molina, MD¹⁹

¹Fred Hutchinson Cancer Center, Seattle, WA
²Children's Minnesota, Minneapolis, MN
³Yale University School of Medicine, New Haven, CT
⁴University of Minnesota Masonic Children’s Hospital, Minneapolis, MN
⁵Virginia Commonwealth University Health System, Richmond, VA
⁶Emory University School of Medicine, Atlanta, GA
⁷Emory University, Atlanta, GA
⁸Sanford Children's Hospital, Sioux Falls, SD
⁹Children's Hospital of Los Angeles, Los Angeles, CA
¹⁰Mary Bridge Children’s Hospital, Tacoma
¹¹Baylor College of Medicine, Houston, TX
¹²University of South Alabama, Mobile, AL
¹³Hasbro Children’s Hospital, Providence, RI
¹⁴Dell Children’s Hospital, Austin, TX
¹⁵University of Alabama Birmingham, Birmingham, AL
¹⁶St. Jude Children's Research Hospital, Memphis, TN
¹⁷Novant Health Hemby Children’s Hospital, Charlotte, NC
¹⁸Nationwide Children's Hospital, Columbus, OH
¹⁹Sutro Biopharma, South San Francisco, CA